Harlan Laboratories Contract Research Services (CRS) and Ipsen have strengthened their collaboration with a new business agreement. The companies have entered into a three-year program to develop early preclinical stage drug candidates, with exclusivity in some specific areas. “This new agreement with Ipsen is in line with our strategy to satisfy the needs of the pharmaceutical industry in the preclinical arena and underlines our willingness to be close to our customers, helping them to make th...